Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
In HF patients, intravenous iron reduces both CV death and HF-related events Jacinthlyn Sylvia17 Jan 2024 10:00 AM ISTA recent study published in the JACC: Heart Failure analyzed the guidelines that advocate the consideration of intravenous iron to reduce heart...
Carvedilol fails to prevent heart failure in anthracycline-exposed survivors of childhood cancer: PREVENT-HF trial Medha Baranwal16 Jan 2024 3:30 AM ISTUSA: A randomised, controlled, phase 2b trial (PREVENT-HF) has shed light on the effect of carvedilol versus placebo on cardiac function in...
Bayer's AskBio begins Phase II GenePHIT trial in Congestive Heart Failure Ruchika Sharma14 Jan 2024 11:30 AM ISTBerlin: Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer...
Decline in blood lead levels associated with reduction in systolic blood pressure: JAHA Dr. Kamal Kant Kohli13 Jan 2024 10:00 AM ISTUSA: Even a small (0.1-1.0 microgram/deciliter) decline in blood lead levels in American Indian adults was associated with reductions in systolic...
Caficrestat may prevent heart failure in diabetic cardiomyopathy patients: ARISE-HF trial Dr. Kamal Kant Kohli11 Jan 2024 10:45 AM ISTUSA: Treatment with caficrestat (AT-001), an investigational oral aldose reductase inhibitor, stabilized cardiac functional capacity in patients with...
COPD exacerbations may heighten long-term cardiovascular risks Medha Baranwal11 Jan 2024 2:00 AM ISTCanada: A recent study has shown moderate and severe chronic obstructive pulmonary disease (COPD) exacerbations to be independent risk factors for...
New protein risk score may predict mortality risk in heart failure patients Medha Baranwal9 Jan 2024 6:30 PM ISTUSA: A tool that measures an array of proteins circulating in the blood can be used to predict the prognosis of patients with heart failure (HF), a...
No need to discontinue SGLT2 inhibitors in response to initial eGFR decline in heart failure patients Medha Baranwal6 Jan 2024 11:00 AM ISTUSA: SGLT2 inhibitors should not be discontinued in response to an initial decline in the estimated glomerular filtration rate (eGFR) among patients...
Cancer drug holds hope for treating inflammatory diseases including gout and heart diseases Dr. Kamal Kant Kohli6 Jan 2024 10:30 AM ISTA cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including...
Two-step screening protocol can predict and prevent heart failure among adults with diabetes Dr. Kamal Kant Kohli5 Jan 2024 10:30 AM ISTUSA: In a recent study published in Circulation, the researchers have described a two-step screening protocol that combines clinical risk assessment...
Top Ten US-FDA Approved Pharmacological Agents in 2023: A Year in Review MDTV Bureau30 Dec 2023 3:51 PM ISTWe come to the end of 2023. Here are top ten pharmacological agents that received US-FDA approval throughout this year, across key therapy areas:1)...
